Glyxambi
Formulated for diabetes management to target blood glucose levels.
- Category
- Diabetes Management
- Active ingredients
- Linagliptin · Empagliflozin
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 25/5mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Glyxambi vary by country.
Glyxambi details
- Condition
- Type 2 Diabetes Mellitus
- Therapeutic class
- DPP-4 Inhibitor; SGLT2 Inhibitor
- Pharmacological class
- Gliptin; Gliflozin
- Precautions and warnings
- monitor for signs of ketoacidosis; maintain adequate hydration
- Minor side effects
- urinary tract infection; nasopharyngitis
- Moderate side effects
- genital infections; polyuria
- Serious side effects
- diabetic ketoacidosis, requires immediate medical attention
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Patient summary
- formulated for diabetes management to target blood glucose levels.
- Supply category
- Pharmacist only, dispensed without a prescription
- Originator
- Boehringer Ingelheim
- Onset Time
- 1–2 hours
- Duration
- 24 hours
- Storage instructions
- Store at room temperature below 30°C.
- Drug interactions
- insulin; sulfonylureas
- Age restrictions
- Adults only.
- Pregnancy and breastfeeding
- Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to components; type 1 diabetes; diabetic ketoacidosis; severe renal impairment
Mechanism of action
Glyxambi improves glucose control by combining two mechanisms. Linagliptin increases incretin hormone levels, enhancing insulin release. Empagliflozin prevents glucose reabsorption in the kidneys, causing excess sugar to be flushed through urine. Combined, these mechanisms improve glycemic stability without overstimulating insulin production in the body.
What you will receive
Glyxambi is the originator brand name, made by Boehringer Ingelheim. We use it here to identify the medicine only; we are not affiliated with Boehringer Ingelheim and do not ship the original Glyxambi.
- You receive a generic equivalent: the same active ingredient (Linagliptin / Empagliflozin) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Glyxambi
Glyxambi combines linagliptin and empagliflozin, a dual-action therapeutic approach for the management of Type 2 Diabetes Mellitus. This medication helps the pancreas produce insulin while simultaneously assisting the kidneys in removing excess sugar from the body. It is supplied as a tablet in the 25/5mg strength.
Buying Glyxambi online
Glyxambi is registered across 14 markets, including Malaysia, the Philippines and Indonesia, with availability also in Taiwan, South Korea and Japan. As a specialized treatment for blood glucose regulation, it remains one of the most ordered medications for patients seeking reliable supply across the region. Ordering online offers a straightforward alternative for expats and residents who may otherwise face difficulty sourcing specific tablets locally, or who prefer consistent access to their established treatment plan.